SLC27A5 and metabolic dysfunction-associated steatotic liver disease: Mice with the hepatic Slc27a5 gene silenced showed that inhibiting the expression of FATP5 reversed NAFLD induced by a high-fat diet and improved hyperglycemia (Doege et al., 2008).